Treatment of sialorrhea by combined use of muscarinic M1 and M3 receptor selective antagonists
Phase 1
- Conditions
- sialorrhea
- Registration Number
- JPRN-UMIN000031765
- Lead Sponsor
- Tokyo Women's medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
retention sialorrhea
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sialorrhea Clinical Scale for PD during 12 weeks
- Secondary Outcome Measures
Name Time Method salivary flow rate (rest and stimulated) during 12 weeks